1. Sung H, Ferlay J, Siegel RL, et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
2. Becker AK, Tso DK, Harris AC, et al (2014) Extrahepatic metastases of hepatocellular carcinoma: A spectrum of imaging findings. Can Assoc Radiol J 65:60–66. https://doi.org/10.1016/j.carj.2013.05.004
3. Yu YM, Cao YS, Wu Z, et al (2020) Colon metastasis from hepatocellular carcinoma: A case report and literature review. World J Surg Oncol 18. https://doi.org/10.1186/s12957-020-01960-2
4. BalajiSubramanian S, Sathiya K, Balaji K, et al (2021) Re-irradiation after stereotactic body radiotherapy for spine metastases from hepatocellular carcinoma: a case report. Reports Pract Oncol Radiother 26:1060–1065. https://doi.org/10.5603/rpor.a2021.0098
5. Tanoue K, Kawasaki Y, Yamasaki Y, et al (2021) Postoperative recurrence with right cervical lymph node metastasis in hepatocellular carcinoma: a case report. Surg Case Reports 7. https://doi.org/10.1186/s40792-021-01352-y
6. Obana A, Yoshinobu Sato MK, Kitamura K, et al (2021) A Case of Multiple Metachronous Metastases from Hepatocellular Carcinoma to Thoracic Spine and Right Adrenal Invading Right Kidney with Tumor Thrombus in the Inferior Vena Cava That Was Treated with Chemotherapy, Radiotherapy, Intravascular Therapy, and S. Gan To Kagaku Ryoho 48:2088–2090
7. Wen T, Jin C, Facciorusso A, et al (2018) Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. HepatoBiliary Surg Nutr 7:353–371. https://doi.org/10.21037/hbsn.2018.08.01
8. Cha C, Fong Y, Jarnagin WR, et al (2003) Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197:753–758. https://doi.org/10.1016/j.jamcollsurg.2003.07.003
9. Zhang H, Zhang W, Jiang L, Chen Y (2022) Recent advances in systemic therapy for hepatocellular carcinoma. Biomark Res 10. https://doi.org/10.1186/s40364-021-00350-4
10. Zhou Q, Jiang H, Zhang J, et al (2018) Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the stat3 pathway. Cancer Manag Res 10:6339–6355. https://doi.org/10.2147/CMAR.S182859
11. Cai J, Sun X, Guo H, et al (2020) Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma. Oncogenesis 9. https://doi.org/10.1038/s41389-020-00287-7
12. Malami I, Abdul AB (2019) Involvement of the uridine cytidine kinase 2 enzyme in cancer cell death: A molecular crosstalk between the enzyme and cellular apoptosis induction. Biomed Pharmacother 109:1506–1510. https://doi.org/10.1016/j.biopha.2018.10.200
13. Malami I, Abdul A, Abdullah R, et al (2016) In Silico Discovery of Potential Uridine-Cytidine Kinase 2 Inhibitors from the Rhizome of Alpinia mutica. Molecules 21:417. https://doi.org/10.3390/molecules21040417
14. Hseu YC, Chiang YC, Gowrisankar YV, et al (2020) The in vitro and in vivo anticancer properties of chalcone flavokawain B through induction of rosmediated apoptotic and autophagic cell death in human melanoma cells. Cancers (Basel) 12:1–24. https://doi.org/10.3390/cancers12102936
15. Malami I, Muhammad A, Etti IC, et al (2017) An in silico approach in predicting the possible mechanism involving restoration of wild-type P53 functions by small molecular weight compounds in tumor cells expressing R273H mutant P53. EXCLI J 16. https://doi.org/10.17179/excli2017-299
16. Malami I, Muhammad A, Abubakar IB, Alhassan AM (2020) Expression of Wild-Type p53 by Curcumin, Alpinetin and Flavokawain B in Colorectal Cancer cells Expressing R273H Mutant p53. Niger J Basic Appl Sci 27:88–94. https://doi.org/10.4314/njbas.v27i2.12
17. Repetto G, del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability/ cytotoxicity. Nat Protoc 3:1125–1131. https://doi.org/10.1038/nprot.2008.75
18. Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329–333. https://doi.org/10.1038/nprot.2007.30
19. Waziri PM, Abdullah R, Yeap SK, et al (2016) Clausenidin from Clausena excavata induces apoptosis in hepG2 cells via the mitochondrial pathway. J Ethnopharmacol 194. https://doi.org/10.1016/j.jep.2016.10.030
20. Waziri PM, Abdullah R, Yeap SK, et al (2016) Clausenidin induces caspase-dependent apoptosis in colon cancer. BMC Complement Altern Med 16. https://doi.org/10.1186/s12906-016-1247-1
21. Etti IC, Rasedee A, Mohd Hashim N, et al (2017) Artonin E induces p53-independent G1 cell cycle arrest and apoptosis through ROS-mediated mitochondrial pathway and livin suppression in MCF-7 cells. Drug Des Devel Ther 11. https://doi.org/10.2147/DDDT.S124324
22. Etti IC, Abdullah R, Kadir A, et al (2017) The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells. PLoS One 12. https://doi.org/10.1371/journal.pone.0182357
23. Malami I, Abdul AB, Abdullah R, et al (2017) Crude extracts, flavokawain B and alpinetin compounds from the rhizome of Alpinia mutica induce cell death via UCK2 enzyme inhibition and in turn reduce 18S rRNA biosynthesis in HT-29 cells. PLoS One 12:. https://doi.org/10.1371/journal.pone.0170233
24. Wang H, Man Q, Huo F, et al (2022) STAT3 pathway in cancers: Past, present, and future. MedComm 3:. https://doi.org/10.1002/mco2.124
25. Malami I, Muhammad A, Abubakar IB, et al (2018) 5,6-dehydrokawain from the rhizome of Alpinia mutica Roxb. induced proangiogenic tumour-derived VEGF of HT-29 colorectal cancer. Nat Prod Res 32:2964–2967. https://doi.org/10.1080/14786419.2017.1392954
26. Niu G, Wright KL, Huang M, et al (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000–2008. https://doi.org/10.1038/sj.onc.1205260
27. Zhang PC, Liu X, Li MM, et al (2020) AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo. Biochem Pharmacol 172:. https://doi.org/10.1016/j.bcp.2019.113771